# Study of the Effect of GM-CSF on Macrophages in Ependymoma

> **NCT04408092** · EARLY_PHASE1 · COMPLETED · sponsor: **University of Colorado, Denver** · enrollment: 6 (actual)

## Conditions studied

- Ependymoma, Recurrent Childhood
- Ependymoma

## Interventions

- **DRUG:** Granulocyte Macrophage Colony Stimulation Factor

## Key facts

- **NCT ID:** NCT04408092
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06-25
- **Primary completion:** 2021-09-21
- **Final completion:** 2023-07-21
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2024-03-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04408092

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04408092, "Study of the Effect of GM-CSF on Macrophages in Ependymoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04408092. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*